ENTITY

Wuhan YZY Biopharma (2496 HK)

Health CareChina
Wuhan YZY Biopharma Co., Ltd. is a biotechnology company that develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related ophthalmologic diseases. The company's pipeline includes product candidates for various solid tumors, ocular neovascularization-related diseases, hemophilia, and inflammatory bowel diseases, utilizing platforms like Y-BODY®, Check-Body, and Nano-Ybody®. It was founded in 2010 and is headquartered in Wuhan, China.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x